Information was received from a healthcare provider (hcp) via a company representative and a consumer regarding a patient receiving fentanyl, bupivacaine, and clonidine via an implanted pump.The indication for pump use was spinal pain.It was reported that two home health agency nurses completed a pump refill on (b)(6) 2022.Two hours later, the patient started to feel sleepy; had low blood pressure; went to the er (emergency room); got narcan; and threw up.No pocket fill occurred as the nurses checked multiple times as they filled the pump.A home health nurse went to the er and reported that 5 ml was missing from the reservoir.The drug was aspirated from the reservoir and the pump was refilled with saline and a bridge bolus was performed.No issues showed in the pump logs.There were no environmental, external, or patient factors that may have led or contributed to the issue.A dye study was being considered, but there were no plans at this time.The issue was not resolved at the time of the report, and it was indicated that the hcp had no further information to provide regarding the event.Additional information was received from the patient on (b)(6) 2022 who reported that she had been having troubles since tuesday ((b)(6) 2022) and was currently in the icu (intensive care unit) at the hospital.She stated that she had reached out to her pump hcp but hadn¿t heard back yet.
|